Washington
+919359902383
+919359902383

Comprehensive Range of Rapid-Acting Insulins for Effective Diabetes Management

HUMAN INSULINS AND ANALOGUES

Comprehensive Range of Rapid-Acting Insulins for Effective Diabetes Management
Export Quality | WHO-GMP Certified | Available in Pens, Cartridges & Vials


HUMAN INSULINS AND ANALOGUES

Rapid-Acting Insulins – Brand, Composition & Dosage Details


Product Name Generic Name Brand Example Composition Available Strengths Packaging Options
Insulin Aspart Recombinant Human Insulin Aspart NovoRapid®, Fiasp® Each mL contains Insulin Aspart 100 IU 100 IU/mL - 3 mL Prefilled Pen- 3 mL Cartridge- 10 mL Vial
Insulin Lispro Recombinant Human Insulin Lispro Humalog®, Admelog® Each mL contains Insulin Lispro 100 IU 100 IU/mL - 3 mL Prefilled Pen- 3 mL Cartridge- 10 mL Vial
Insulin Glulisine Recombinant Human Insulin Glulisine Apidra® Each mL contains Insulin Glulisine 100 IU 100 IU/mL - 3 mL Prefilled Pen- 3 mL Cartridge- 10 mL Vial



Key Notes

  • Onset of Action: Within 10–20 minutes after subcutaneous injection

  • Peak Effect: 1–3 hours

  • Duration: 3–5 hours

  • Indications: Mealtime (postprandial) glucose control in Type 1 and Type 2 diabetes

  • Administration Route: Subcutaneous or intravenous (as per clinical need)

  • Storage: 2°C–8°C (Refrigerated), Do not freeze

North America:
United States, Canada, Mexico

Latin America:
Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela, Ecuador, Bolivia, Uruguay, Paraguay, Costa Rica, Panama, Guatemala, Honduras, El Salvador, Nicaragua, Belize, Cuba, the Dominican Republic, Haiti, Jamaica, Trinidad and Tobago, and all other countries in the region.
Southern Africa:
South Africa, Namibia, Botswana, Zimbabwe, Lesotho, Eswatini (Swaziland), Angola, Zambia, Mozambique, Malawi, and neighboring countries.

Middle East:
Saudi Arabia, United Arab Emirates, Qatar, Kuwait, Bahrain, Oman, Iraq, Jordan, Lebanon, Syria, Yemen, Israel, Palestine, Iran, Turkey, and all other countries in the region.

Contact 
WhatsApp Number 





 2025-06-09T09:18:09

Other Pages

View all pages